Not yet recruitingInterventionalNot ApplicableLast updated Aug 10, 2026

VividFlo System Validation Study

A Prospective Evaluation of the Safety and Effectiveness of VividFlo Implantation Using a Partial-Thickness Scleral Flap Technique and The VividFlo System.

Overview

ClinicalTrials.gov ID: NCT07754201
Lead Sponsor: VividWhite Pty LtdINDUSTRY
Brief Summary: This is a 10-participant study to assess the VividFlo System and surgical implantation using a modified technique.
Study Type: Interventional

Status

Overall Status: Not yet recruiting
Start Date: Aug 10, 2026Estimated
Primary Completion Date: Dec 2027Estimated
Completion Date: Mar 2028Estimated

Study Record Dates

First Submitted: Aug 4, 2026
First Submitted that Met QC Criteria: Aug 4, 2026
First Posted: Aug 10, 2026Actual
Last Update Submitted that Met QC Criteria: Aug 4, 2026
Last Update Posted: Aug 10, 2026Actual
Last Verified: Aug 2026

NCT06176170Active, not recruiting

VividWhite Glaucoma Implant (VW-51) Pivotal Study

NCT07730424Completed

VW-50 Feasibility Study

NCT07220876Recruiting

Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma

NCT07140692Completed

EFFECTIVENESS AND SAFETY ASSESSMENT OF THE VISTA VITRECTOMY PROBE

NCT02928289Terminated

Safety and Effectiveness of the Sight Sciences VISCO™360 Versus SLT in Primary Open Angle Glaucoma

NCT03469297Completed

Early Feasibility Study of the Brown Glaucoma Implant in Patients With Severe Visual Impairment or No Light Perceived